[Federal Register Volume 67, Number 75 (Thursday, April 18, 2002)]
[Notices]
[Page 19190]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-9386]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol 
Effect: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal advisory committee 
meeting.

    Name: National Task Force on Fetal Alcohol Syndrome and Fetal 
Alcohol Effect (NTFFASFAE).
    Times and Dates: 8:30 a.m.-4:30 p.m., May 16, 2002. 8:30 a.m.-3 
p.m., May 17, 2002.
    Place: Doubletree Hotel Atlanta Buckhead, 3340 Peachtree Road, 
NE, Atlanta, Georgia 30326, telephone 404/231-1234, fax 404/231-
5236.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 65 people.
    Purpose: The Secretary is authorized by the Public Health 
Service Act, Section 399G, (42 U.S.C. Section 280f, as added by 
Public Law 105-392) to establish a National Task Force on Fetal 
Alcohol Syndrome and Fetal Alcohol Effect to: (1) foster 
coordination among all governmental agencies, academic bodies and 
community groups that conduct or support Fetal Alcohol Syndrome 
(FAS) and Fetal Alcohol Effect (FAE) research, programs and 
surveillance; and (2) to otherwise meet the general needs of 
populations actually or potentially impacted by FAS and FAE.
    Matters To Be Discussed: Discussions will focus on ways the Task 
Force can collaborate with CDC on issues of diagnosis of FAS/FAE and 
to better equip health care providers to recognize the disorder; the 
special needs of birth mothers of children with FAS/FAE; a 
discussion of the Substance Abuse and Mental Health Services 
Administration FAS/FAE Center for Excellence on their initial 
``stakeholders'' meetings and the interaction with the Task Force; 
an update on progress with the ICCFAS; new research items presented 
by the CDC; and a discussion of the implementation of the Task Force 
recommendations by various governmental agencies. Additional agenda 
items include: Working group updates; discussion of future topics, 
and scheduling the next meeting.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: R. Louise Floyd, DSN, RN, 
Designated Federal Official, National Center on Birth Defects and 
Developmental Disabilities, CDC, 4700 Buford Highway, NE, (F-49), 
Atlanta, Georgia 30333, telephone 770/488-7372, fax 770/488-7361.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: April 9, 2002.
Alvin Hall,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 02-9386 Filed 4-17-02; 8:45 am]
BILLING CODE 4163-18-P